RNS Number : 7952A Spire Healthcare Group PLC 14 March 2025 Spire Healthcare Group plc 14 March 2025 Notification of Transactions of Persons Discharging Managerial Responsibilities Grant of Deferred Share Bonus Plan (DSBP) Awards Spire Healthcare Group plc (the Company) announces that on 13 March 2025, awards (the DSBP Awards) were granted over the Company's ordinary shares in the form of nil-cost options to the Directors named below, under the Company's DSBP. Under the DSBP, Executive Directors are required to defer a proportion of their gross bonus, received in respect of the financial year ended 31 December 2024, into shares in the Company for a period of three years. The Directors listed below have the following interest in shares as deferred share bonus awards under the DSBP: * To be disclosed in the 2024 Annual Report and Accounts The share price used to determine the number of Deferred Shares subject to award was 176.0 pence, being the mid-market closing share price on 12 March 2025 (the dealing day prior to the awards being made). The DSBP Awards will vest on the third anniversary of the grant date on 13 March 2028. The transaction place is London. Name of contact for queries: Amie Gramlick                                                            investors@spirehealthcare.com Director of Investor Relations Spire Healthcare Group plc Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHBSGDXUSBDGUS